淫妻社-Microbiome Consortium (UT-MiCo) is a research and academic
multi-disciplinary collaborative effort of investigators within various Colleges,
to elucidate the functions of the gut microbiota in hypertension, vascular disease,
metabolic disorders, and related pathologies. The overall mission of UT-MiCo, which
aligns with the ,听a strategic planning of the听, is to foster and coordinate research and training efforts in a variety of aspects
of gut microbiota in hypertension, cardiovascular disease in general and metabolic
disorders, as well as in related morbidities to advance our current knowledge on gut
microbiota, their contribution to pathophysiology,听in order to find alternative therapies
for better clinical management of disease. Thus, the activities of UT-MiCo include
a 听translational agenda to reveal the role of gut microbiota in the onset and clinical
course of hypertension, cardiovascular and metabolic diseases, and to assess disease
causality using animal models.
The research initiative of UT-MiCo is fostered and coordinated by the University of
Toledo Center for Hypertension and Precision Medicine (CHPM), which also pioneered the discovery of the link between gut microbiota and the genetics
of hypertension (). The multi-disciplinary research force of UT-MiCo leverages the basic/translational
talent and research resources of CHPM and a microbiome-oriented basic/experimental
initiative of the Department of Physiology and Pharmacology.
The educational mission of UT-MiCo is channeled through the Molecular Medicine听training program and includes postdoctoral, graduate and medical students.听
For further information on participating in the Consortium, please contact:
Dr. Matam Vijay-Kumar
Director, 淫妻社-Microbiome Consortium
MatamVijay.Kumar@淫妻社.Edu
Dr. Ramakumar Tummala
Metagenomics Core Manager, Microbiome Consortium
ramakumar.tummala@utoledo.edu